Carbenoxolone-mediated cytotoxicity inhibits Vaccinia virus replication in a human keratinocyte cell line

Ismar Haga, Jennifer L. Simpson, Philippa C. Hawes, Philippa Beard

Research output: Contribution to journalArticlepeer-review

Abstract

The re-emergence of poxviral zoonotic infections and the threat of bioterrorism emphasise the demand for effective antipoxvirus therapies. Here, we show that carbenoxolone, a pharmacological inhibitor of gap junction function and a compound widely used in cell culture, is capable of hindering the replication of Vaccinia virus, the prototypical poxvirus, in a gap junction-independent manner in a human keratinocyte cell line. Viral protein synthesis occurs in the presence of carbenoxolone but infectious virion formation is minimal, indicating that carbenoxolone blocks viral morphogenesis. Initial viability tests suggested that
carbenoxolone was not toxic to cells. However, electron microscopic analysis of
carbenoxolone treated cells revealed that it alters the cellular endomembrane system. This widespread ultrastructural damage prevents Vaccinia virus virion assembly. These results strengthen the need for thorough characterisation of the effects of antiviral compounds on the cellular ultrastructure.
Original languageEnglish
Article number 16956
JournalScientific Reports
Volume8
DOIs
Publication statusPublished - 16 Nov 2018

Fingerprint Dive into the research topics of 'Carbenoxolone-mediated cytotoxicity inhibits Vaccinia virus replication in a human keratinocyte cell line'. Together they form a unique fingerprint.

Cite this